esaxerenone   Click here for help

GtoPdb Ligand ID: 9894

Synonyms: CS-3150 | XL-550
Approved drug PDB Ligand
esaxerenone is an approved drug (Japan (2019))
Compound class: Synthetic organic
Comment: Selective antagonist of the mineralocorticoid receptor that has progressed to clinical trials in a number of indications [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 96.78
Molecular weight 466.12
XLogP 3.38
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCCn1cc(c(c1c1ccccc1C(F)(F)F)C)C(=O)Nc1ccc(cc1)S(=O)(=O)C
Isomeric SMILES OCCn1cc(c(c1c1ccccc1C(F)(F)F)C)C(=O)Nc1ccc(cc1)S(=O)(=O)C
InChI InChI=1S/C22H21F3N2O4S/c1-14-18(21(29)26-15-7-9-16(10-8-15)32(2,30)31)13-27(11-12-28)20(14)17-5-3-4-6-19(17)22(23,24)25/h3-10,13,28H,11-12H2,1-2H3,(H,26,29)
InChI Key NOSNHVJANRODGR-UHFFFAOYSA-N
References
1. Kato M, Furuie H, Shimizu T, Miyazaki A, Kobayashi F, Ishizuka H. (2018)
Single- and multiple-dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjects.
Br J Clin Pharmacol, 84 (8): 1821-1829. [PMID:29688582]
2. Piotrowski DW. (2012)
Mineralocorticoid receptor antagonists for the treatment of hypertension and diabetic nephropathy.
J Med Chem, 55 (18): 7957-66. [PMID:22866979]